Sunday, July 3, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home News

Whole-genome sequencing project sheds new light on the diversity of Candida glabrata

by Medical Finance
in News
Whole-genome sequencing project sheds new light on the diversity of Candida glabrata
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

New research from the University of Exeter reports the largest ever whole-genome sequencing project for the potentially fatal yeast infection Candida glabrata from hospitals across Scotland.

Candida glabrata is a type of yeast that can cause disease in humans. It most commonly affects the urinary tract, genitals, mouth, and the bloodstream. If it is not caught, these infections can become deadly. It also has a very high resistance to certain antifungal drugs, so understanding why resistance occurs is key to knowing how to treat it effectively.

The new research, published in Genetics, used samples from eight hospitals in Scotland to sequence the genome of Candida glabrata. This led to the discovery of a variety of new information on the species. This includes information on how they reproduce and the genetic diversity. It also found that genes that make it more likely to be infectious have an advantage for survival, and the drug-resistance genes often evolve within patients.

The discovery of this information gives scientists an advantage when it comes to treating candida glabrata. A better understanding of the genes involved allows researchers to focus their work in ways that were not possible before. It also helps aid understanding on how the pathogen spreads, which is important to identifying infections.

Our study sheds new light on the genetic diversity of Candida glabrata. We have demonstrated that this deadly human fungal pathogen is being spread between continents, probably by humans, and recombining to form new populations, which is likely contributing to its high virulence and increasing drug resistance.”


Dr Rhys Farrer, Principal Investigator at the MRC Centre for Medical Mycology, University of Exeter

Source:

Journal reference:

Helmstetter, N., et al. (2022) Population genetics and microevolution of clinical Candida glabrata reveals recombinant sequence types and hyper-variation within mitochondrial genomes, virulence genes and drug-targets. Genetics. doi.org/10.1093/genetics/iyac031.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

PhoreMost and POLARISqb announce a multi-target collaboration to investigate next-generation cancer therapies

Novel strategy can shrink tumors and prolong survival in mice

by Medical Finance
July 2, 2022
0

A research team based at the University of Ottawa and The Ottawa Hospital has developed a virus that infects and...

Horizontal gene transfer between viruses and hosts plays a major role in driving evolution

Spatial transcriptomics-driven gene mapping offers new insights into inflammatory bowel disease

by Medical Finance
July 2, 2022
0

Using a technique called spatial transcriptomics, researchers at Karolinska Institutet in Sweden have analyzed the gene expression in the mouse...

Study: Nanocell COVID-19 Vaccine Elicits Inkt-Licensed Dendritic Cells to Produce High Affinity Antibodies Neutralizing Variants of Concern. Image Credit: Yurchanka Siarhei / Shutterstock.com

Nanocell COVID-19 vaccine elicits potent neutralizing response

by Medical Finance
July 2, 2022
0

Even as the coronavirus disease 2019 (COVID-19) pandemic persists, newer and more effective vaccines are being developed using novel platforms,...

Macrophages in the arteries can “sniff” out their surroundings and cause inflammation

Study provides new understanding of caffeine’s protective effects on the cardiovascular system

by Medical Finance
July 2, 2022
0

Scientists have a new understanding of the protective effects of caffeine on the cardiovascular system. While its stimulant effects have...

Study: SARS-CoV-2 impairs the disassembly of stress granules and promotes ALS-associated amyloid aggregation. Image Credit: Kateryna Kon / Shutterstock.com

Evidence of an increased risk of neurodegeneration after SARS-CoV-2 infection

by Medical Finance
July 3, 2022
0

The current coronavirus disease 2019 (COVID-19) pandemic, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a...

Surveying communities may be a useful tool for predicting COVID-19 case trajectories

Study reports accumulation of SARS-CoV-2 RNA in sewer biofilms

by Medical Finance
July 3, 2022
0

During the COVID-19 pandemic, monitoring the levels of SARS-CoV-2 RNA in wastewater entering treatment plants has been one way that...

Next Post
Scrapping many Covid testing measures is a grave mistake, says London Medical Laboratory

Cannabidiol found to inhibit SARS-CoV-2 infection in human cells and mice

Scientists discover antibody that inhibits a broad range of sarbecoviruses

Some states still pushing ineffective covid antibody treatments

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms. Image Credit: Sylfida/Shutterstock
    Current progress in SARS-CoV-2 vaccine candidates
  • bacteria Sebastian Kaulitzki 46826fb7971649bfaca04a9b4cef3309 620x480
    Rising temperatures lead to increased prevalence of Vibrio bacteria in UK waters
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply